Overview


Adipose tissue, accessible in ample amounts via liposuction, is a plentiful source of stem cells for therapeutic purposes. The ongoing advancements in stem cell research have yielded enhanced comprehension and methodologies for isolating and leveraging adipose-derived stem cells, propelling market progression. These cells possess the capacity to differentiate into diverse cell types, rendering them invaluable in addressing a broad spectrum of medical conditions and injuries. Additionally, adipose-derived stem cells exhibit a lower likelihood of immune rejection, diminishing the necessity for immunosuppressive drugs during transplantation. Extracting these stem cells is less invasive than alternative sources like bone marrow, reducing patient discomfort and quicker recovery periods.

However, it's imperative to acknowledge that using stem cells, including those derived from adipose tissue, is subject to stringent regulatory oversight. Ensuring adherence to regulatory requisites can pose a substantial challenge. Furthermore, although adipose-derived stem cell therapy displays promise, specific applications may have limited availability of long-term clinical data, potentially impacting the confidence of physicians and patients. Establishing standardized protocols for isolating, expanding, and applying adipose-derived stem cells may be necessary to mitigate variations in treatment outcomes.

FutureWise Market Research has published a report that provides an insightful analysis of Adipose Derived Stem Cell Therapy Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Adipose Derived Stem Cell Therapy Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • BioRestorative Therapies, Inc.
  • Celltex Therapeutics Corporation
  • Antria, Inc.
  • Cytori Therapeutics Inc.
  • Intrexon Corporation
  • Mesoblast Ltd.
  • iXCells Biotechnologies
  • Pluristem Therapeutics, Inc.
  • Thermo Fisher Scientific, Inc.
  • Tissue Genesis, Inc.
  • Cyagen US Inc.
  • Celprogen, Inc.
  • Lonza Group

(Note: The list of the major players will be updated with the latest market scenario and trends)

Adipose tissue, accessible in ample amounts via liposuction, is a plentiful source of stem cells for therapeutic purposes. The ongoing advancements in stem cell research have yielded enhanced comprehension and methodologies for isolating and leveraging adipose-derived stem cells, propelling market progression. These cells possess the capacity to differentiate into diverse cell types, rendering them invaluable in addressing a broad spectrum of medical conditions and injuries. Additionally, adipose-derived stem cells exhibit a lower likelihood of immune rejection, diminishing the necessity for immunosuppressive drugs during transplantation. Extracting these stem cells is less invasive than alternative sources like bone marrow, reducing patient discomfort and quicker recovery, hence driving the market.

However, it's imperative to acknowledge that using stem cells, including those derived from adipose tissue, is subject to stringent regulatory oversight. Ensuring adherence to regulatory requisites can pose a substantial challenge. Furthermore, although adipose-derived stem cell therapy displays promise, specific applications may have limited availability of long-term clinical data, potentially impacting the confidence of physicians and patients and hindering the market.

By Cell Type

  • Allogeneic Stem Cells
  • Autologous Stem Cells

By Product Type

  • Cell lines
  • Culture Media

By Application

  • Therapeutic Application
  • Research Application

By End User

  • Cell & Tissue Banks
  • Biotechnology & Pharmaceutical organizations
  • Research & Academic Organizations

By Region

  • North America
  • Europe
  •  Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to increase in awareness about role of regenerative medicine in the market, robust healthcare infrastructure, the prominent presence of key industry players, and heightened research endeavors in this geographical region. Conversely, the Asia-Pacific region is poised for substantial expansion in the forecast period due to an upswing in research initiatives, access to extensive untapped markets, a sizable population base, and an escalating demand for high-quality healthcare services.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Adipose Derived Stem Cell Therapy Market By Cell Type, By Product Type, By Application, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Adipose Derived Stem Cell Therapy Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Adipose Derived Stem Cell Therapy Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Adipose Derived Stem Cell Therapy Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Adipose Derived Stem Cell Therapy Market, By Cell Type Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Allogeneic Stem Cells
      2. Autologous Stem Cells
  • 8.  Adipose Derived Stem Cell Therapy Market, By Product Type Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Cell lines
      2. Culture Media
  • 9.  Adipose Derived Stem Cell Therapy Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Therapeutic Application
      2. Research Application
  • 10.  Adipose Derived Stem Cell Therapy Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Cell & Tissue Banks
      2. Biotechnology & Pharmaceutical organizations
      3. Research & Academic Organizations
  • 11.  North America Adipose Derived Stem Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.  Latin America Adipose Derived Stem Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.  Europe Adipose Derived Stem Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.  Asia Pacific Adipose Derived Stem Cell Therapy Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 15.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. BioRestorative Therapies, Inc.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Celltex Therapeutics Corporation
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Antria, Inc.
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Cytori Therapeutics Inc.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Intrexon Corporation
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Mesoblast Ltd.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. iXCells Biotechnologies
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Pluristem Therapeutics, Inc.
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Thermo Fisher Scientific, Inc.
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Tissue Genesis, Inc.
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. Cyagen US Inc.
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Celprogen, Inc.
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Lonza Group
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client

    •    


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11